Nakuru: The Nakuru County government, supported by the national government and development partners, has implemented advanced diagnostic equipment to combat a challenging form of tuberculosis. This development is expected to significantly aid doctors in diagnosing and managing TB cases more efficiently.
According to Kenya News Agency, County TB and Leprosy Coordinator Dr. Neimah Barasa emphasized the impact of these advanced diagnostic tools, which have facilitated faster and more accurate diagnosis of TB. The adoption of ultra-portable digital chest X-ray machines equipped with Artificial Intelligence (AI) has improved the screening process, increasing the number of cases detected and reducing community transmission.
Dr. Barasa highlighted that the AI-powered portable X-ray machine, now stationed at Molo Sub County Hospital, will serve residents from Njoro, Kuresoi South, and Kuresoi North Sub-Counties. This technology supports active case finding strategies and aligns with national TB control priorities. By enabling same-day screening and results, the system enhances timely linkage to care and improves treatment outcomes.
The digital X-ray machines, which emit lower radiation doses, are particularly effective in hard-to-reach communities, offering instant image analysis and improving diagnostic accuracy. Dr. Barasa noted that the deployment of this technology has also aided in detecting other conditions such as chronic obstructive pulmonary diseases and asthma, with patients being referred for further management.
In addition to the advanced X-ray technology, Nakuru County has implemented multiple modern diagnostic tools, including GeneXpert machines and TrueNat point-of-care tests, to improve TB diagnosis and treatment. Dr. Barasa mentioned that the county has made significant progress in TB management, with numerous health facilities now equipped to provide treatment and diagnosis.
The introduction of AI-enabled diagnostic tools at Nakuru County Teaching and Referral Hospital (NCTRH) is part of a national initiative supported by the World Health Organization and USAID. The TrueNat test, endorsed by WHO, offers rapid molecular testing for TB and drug resistance, enabling timely treatment adjustments.
Dr. Barasa emphasized the importance of early detection and treatment, particularly for individuals with Latent TB who may not display symptoms. The county has trained over 100 Community Health Promoters to enhance early prevention, detection, and treatment efforts at the grassroots level.
Efforts to combat TB in Kenya face various challenges, including limited access to healthcare and the concurrent HIV epidemic. However, the county's initiatives and the adoption of advanced technology represent significant strides in addressing the TB burden, particularly among high-risk groups.